NAMS — NewAmsterdam Pharma NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for NewAmsterdam Pharma NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	60.4	468	340	834	636
Net Total Receivables	4.88	2.07	1.88	21.3	23.2
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66.9	478	347	863	676
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.216	0.154	0.101	0.673	0.568
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	68	478	347	865	769
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.2	36.1	49.9	107	85.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.4	48.4	58.7	107	85.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	56.6	430	288	758	683
Total Liabilities & Shareholders' Equity	68	478	347	865	769
Total Common Shares Outstanding